|
End-of-day quote
Nasdaq
2026-09-01
|
5-day change | 1st Jan Change | ||
| 5.240 USD | +0.96% |
|
+3.76% | +2.14% |
| 08-31 | Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80 | MT |
| 08-31 | Alvotech's Application for Proposed Entyvio Biosimilar Accepted for US FDA Review | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
ALVO 5.240 $
+0.96%
5.39M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ALVO | 5.240USD | +0.96% | 5.39M $ | |
NYSE
| ALVO | 5.240USD | +0.96% | 5.39M $ | |
|
Nasdaq Iceland
| ALVO | 634.00ISK | 0.00% | 154M kr | |
|
CBOE
| ALVO | 5.255USD | +1.15% | 417K $ | |
|
Boerse Muenchen
| Z45 | 4.550EUR | +1.34% | 2.68K € | |
|
Deutsche Boerse AG
| Z45 | 4.270EUR | +0.23% | 0 € | |
|
Börse Stuttgart
| Z45 | 4.410EUR | +1.15% | 0 € | |
Nasdaq Stockholm
| ALVO SDB | 48.90SEK | +0.41% | 4.72M kr | |
|
CBOE
| 48.32SEK | -1.78% | 66.11K kr | ||
|
Deutsche Boerse AG
| Z450 | 4.200EUR | +7.69% | 1.05K € | |
|
CBOE
| 33.35SEK | 0.00% | 0 kr |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 5.25 | 5.25 | 5.26 |
| Spread/Res. | -0.19% | -0.19% | -0.38% |
| Spread/Supp. | +27.18% | +27.18% | +71.24% |
| Support | 4.12 | 4.12 | 3.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALVO Stock
- Charts Alvotech
Select your edition
All financial news and data tailored to specific country editions
